🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the safety and tolerance...
Status
Completed
Location
H. Manresa
Start Date
2012-11
Trial ID
NCT01734265
Specific immunotherapy for IgE mediated sensitization to grass pollen 4 co...
Status
Completed
Location
Hippke, Ear-Nose-Throat specialist
Start Date
2012-10
Trial ID
NCT01634958
Treatments Being Tested
Safety study of Depigoid vaccine Dermatophagoides pteronyssinus or 50% Derm...
Status
Terminated
Location
Complejo Hospitalario Torrecárdenas
Start Date
2012-06
Trial ID
NCT01591343
Treatments Being Tested
Specific immunotherapy for subcutaneous application: Dose finding study to ...
Status
Completed
Location
Dermatology Weber
Start Date
2010-06
Trial ID
NCT01144429
Treatments Being Tested
The CSMS was defined by the European Academy of Allergy and Immunology Task...
Status
Completed
Location
Dr. med Andrea Kienle-Gogolok
Start Date
2018-09-09
Trial ID
NCT03850626
Treatments Being Tested
The objective of this trial is to evaluate the clinical effectiveness of th...
Status
Terminated
Location
Hospital Universitario La Fé
Start Date
2008-01
Trial ID
NCT00622362
The purpose of this study is evaluate the efficacy of a depigmented grass e...
Status
Completed
Location
Hospital Infanta Leonor
Start Date
2010-10
Trial ID
NCT02126111
Treatments Being Tested
Specific immunotherapy for IgE mediated sensitization to birch pollen. Long...
Status
Completed
Location
Hautarztpraxis
Start Date
2012-09-17
Trial ID
NCT01694836
Treatments Being Tested
The objective of this trial is to assess the clinical efficacy of the modif...
Status
Completed
Location
H. Germans Trias i Pujol
Start Date
2008-02
Trial ID
NCT00916760
Treatments Being Tested
Efficacy/ safety for the combination of anti-IgE (Omalizumab) and specific ...
Status
Completed
Location
Novartis Investigator site
Start Date
2006-02
Trial ID
NCT00396409
Treatments Being Tested